A maternal serum metabolite ratio predicts fetal growth restriction at term
- 11 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (3), 348-353
- https://doi.org/10.1038/s41591-020-0804-9
Abstract
Fetal growth restriction (FGR) is the major single cause of stillbirth1 and is also associated with neonatal morbidity and mortality2,3, impaired health and educational achievement in childhood4,5 and with a range of diseases in later life6. Effective screening and intervention for FGR is an unmet clinical need. Here, we performed ultrahigh performance liquid chromatography–tandem mass spectroscopy (UPLC–MS/MS) metabolomics on maternal serum at 12, 20 and 28 weeks of gestational age (wkGA) using 175 cases of term FGR and 299 controls from the Pregnancy Outcome Prediction (POP) study, conducted in Cambridge, UK, to identify predictive metabolites. Internal validation using 36 wkGA samples demonstrated that a ratio of the products of the relative concentrations of two positively associated metabolites (1-(1-enyl-stearoyl)-2-oleoyl-GPC (P-18:0/18:1) and 1,5-anhydroglucitol) to the product of the relative concentrations of two negatively associated metabolites (5α-androstan-3α,17α-diol disulfate and N1,N12-diacetylspermine) predicted FGR at term. The ratio had approximately double the discrimination as compared to a previously developed angiogenic biomarker7, the soluble fms-like tyrosine kinase 1:placental growth factor (sFLT1:PlGF) ratio (AUC 0.78 versus 0.64, P = 0.0001). We validated the predictive performance of the metabolite ratio in two sub-samples of a demographically dissimilar cohort, Born in Bradford (BiB), conducted in Bradford, UK (P = 0.0002). Screening and intervention using this metabolite ratio in conjunction with ultrasonic imaging at around 36 wkGA could plausibly prevent adverse events through enhanced fetal monitoring and targeted induction of labor.Keywords
This publication has 35 references indexed in Scilit:
- Maternal and fetal risk factors for stillbirth: population based studyBMJ, 2013
- Researching New Methods of Screening for Adverse Pregnancy Outcome: Lessons from Pre-eclampsiaPLoS Medicine, 2012
- The “Great Obstetrical Syndromes” are associated with disorders of deep placentationAmerican Journal of Obstetrics and Gynecology, 2011
- Prepregnancy Risk Factors for Antepartum Stillbirth in the United StatesObstetrics & Gynecology, 2010
- Gestational Age at Delivery and Special Educational Need: Retrospective Cohort Study of 407,503 SchoolchildrenPLoS Medicine, 2010
- Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction studyBMC Pregnancy and Childbirth, 2008
- Born in Bradford, a cohort study of babies born in Bradford, and their parents: Protocol for the recruitment phaseBMC Public Health, 2008
- A simple radioimmunoassay for estriol 3-sulfate in pregnancy plasma without deconjugationSteroids, 1985
- Ultrasound and biochemical findings in intrauterine growth retardationjpme, 1976
- Excretion of Steroid Hormones in AdultsJBIC Journal of Biological Inorganic Chemistry, 1970